Business Wire

CeloNova Biosciences Receives FDA Approval of COBRA PzF™ Stent System

SAN ANTONIO--(BUSINESS WIRE)--CeloNova BioSciences, Inc. (CeloNova) today announced that it has received U.S. Food and Drug Administration (FDA) approval of its first-in-class COBRA PzF™ NanoCoated ...
TCTMD

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

SAN ANTONIO., CeloNova BioSciences, Inc. announced today that it has received conditional approval to start an investigational device exemption (IDE) trial to study the COBRA PzF coronary stent system ...
TCTMD

CeloNova’s Coronary Stent System Could Mean Faster Healing of Arteries and Greatly Reduced Use of Blood-thinning Medication

SAN ANTONIO. -- CeloNova BioSciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted approval to start an investigative device exemption (IDE) trial for its novel ...
FierceBiotech

CeloNova’s nanocoated coronary stent wins FDA nod

The FDA approved CeloNova Biosciences’ nanocoated coronary stent for the treatment of obstructive coronary artery disease. The device could be an alternative for patients who are unsuitable for ...